BioLargo, Inc. Share Price Other OTC
Equities
BLGO
US09065A1007
Commodity Chemicals
Sales 2024 * | 19.05M 1.52B | Sales 2025 * | 25.76M 2.05B | Capitalization | 104M 8.32B |
---|---|---|---|---|---|
Net income 2024 * | -1M -79.69M | Net income 2025 * | - 0 | EV / Sales 2024 * | 5.48 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.05 x |
P/E ratio 2024 * |
-35.3
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.77% |
Latest transcript on BioLargo, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 31/05/02 |
Director of Finance/CFO | 68 | 31/01/08 | |
Chief Operating Officer | 55 | 31/05/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 27/04/06 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 31/03/07 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 31/05/02 |
1st Jan change | Capi. | |
---|---|---|
+5.80% | 105B | |
-3.11% | 63.99B | |
+51.90% | 42.95B | |
+17.44% | 39.2B | |
+6.62% | 33.01B | |
+13.00% | 20.33B | |
+15.64% | 17.29B | |
+22.55% | 15.72B | |
+7.34% | 14.72B |